Interestingly, the inhibition of PD‐L1 palmitoylation by mutating the palmitoylation site or knocking down of palmitoylation enzyme with shRNA sensitized breast cancer cell lines to T‐cell killing, thereby suppressing tumor growth in mice [30]. This evidence concerns the gene CD274 and neoplasm.